The discussion follows questions councilors had during the last needle exchange workshop earlier this month about how to ...

If you're stocking up on Thanksgiving meal must-haves, this one can't be missed. Add it to your Amazon cart now.

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Now imagine swapping some of that hardware for medicated skin cream that never pokes your skin. That is the vision behind a new Nature study describing a polymer that can haul insulin straight through ...

The ruling by reimbursement authority NICE means that Amvuttra (vutrisiran) can be used to treat wild-type or hereditary ATTR ...

Tremane Wood had just eaten the meal he figured would be his last: fried catfish, okra, coleslaw, chocolate ice cream, and Dr Pepper. He was moments away from being administered a lethal injection to ...

The Injector Collective is a revolutionary platform designed specifically for licensed injectors and medspa professionals. It ...

The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...